PARIS–(BUSINESS WIRE)–TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today Romain Attard has been appointed Chief Financial Officer of TISSIUM. Mr. Attard joins TISSIUM with an extensive background in corporate finance and Equity Capital Markets having supported a number of mid-cap financing events in Europe and in the U.S, as well as originating and executing mergers and acquisitions among public and private compani